Peng Zhang
CEO
Copoly.ai
Vancouver, Canada
1 profile visit
At Copoly, we are developing blood-based early cancer detection platform OncoSage. We can detect stage I/II lung cancer with 97% sensitivity and 93% specificity
My organisation
Copoly.ai is an Ontario-based AI and life sciences company dedicated to improving how cancer is detected and diagnosed. Its flagship platform, OncoSage, is a blood-based early cancer detection solution that combines advanced multi-omics and artificial intelligence to identify cancer at very early stages, with a current focus on lung cancer. By aiming to make testing more accessible, less invasive, and more cost-effective, Copoly.ai is building tools that can support earlier intervention, improve clinical decision-making, and expand access to precision diagnostics in real-world healthcare settings.
About me
CEO and co-founder of Copoly.ai, an Ontario-based AI and life sciences company focused on transforming early cancer detection. With a background spanning AI, data science, and healthcare innovation, Peng works at the intersection of technology, clinical impact, and commercialization, building solutions that help bring cutting-edge cancer diagnostics closer to real-world patient care.